Exosomes from patients with Kras chemoresistant lung cancer patients have been shown to remodel metabolism in a PKM2-dependent manner to maintain lung cancer cell metabolic chemoresistance (Petanidis et al., 2020). This evidence concerns the gene PKM and lung carcinoma.